Streptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the Alaska Native Medical Center

References

• Jenkins SG, Brown SD, Farrell DJ. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US years 1–4. Ann Clin Microbiol Antimicrob. 2008; 7: 1–11.
   PubMedGoogle Scholar
• Lin W, Lo W, Chou C, Chen Y, Tsai S, Chu M, etal. Antimicrobial resistance patterns and serotype distribution of invasive streptococcus pneumoniae isolates from children in Taiwan from 1999 to 2004. Diagn Microbiol Infect Dis. 2006; 56: 189–96.
   PubMed Web of Science ®Google Scholar
• Hicks LA, Chien Y, Taylor TH, Haber M, Klugman KP. Active Bacterial Core Surveillance (ABCs) Team. Outpatient antibiotic prescribing and nonsusceptible streptococcus pneumoniae in the United States, 1996–2003. Clin Infect Dis. 2011; 53: 631–9.
   Web of Science ®Google Scholar
• Rudolph KM, Parkinson AJ, Reasonover AL, Bulkow LR, Parks DL, Butler JC. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska, 1991–1998. J Infect Dis. 2000; 182: 490–6.
   PubMed Web of Science ®Google Scholar
• Hennessy TW, Singleton RJ, Bulkow LR, Bruden DL, Hurlburt DA, Parks D, etal. Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance, and colonization in Alaska Natives: progress toward elimination of a health disparity. Vaccine. 2005; 23: 5464–73.
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Fussi P, Feierl G, Wagner-Eibel U, Leitner E, Masoud L, etal. Antimicrobial resistance of Streptococcus pneumoniae in southeast Austria, 1997–2008. Int J Antimicrob Agents. 2010; 36(1): 24–7.
   Web of Science ®Google Scholar
• Jenkins S, Farrell DJ. Increase in pneumococcus macrolide resistance, United States. Emerg Infect Dis. 2009; 15(8): 1260–4.
   PubMed Web of Science ®Google Scholar
• Pihlajamaki M, Kotilainen P, Kaurila T, Klaukka T, Palva E, Huovinen P, etal. Macrolide-resistant streptococcus pneumoniae and use of antimicrobial agents. Clin Infect Dis. 2001; 33: 483–8.
   PubMed Web of Science ®Google Scholar
• Priest P, Yudkin P, McNulty C, Mant D. Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study. BMJ. 2001; 323: 1037–41.
   Google Scholar
• Harbarth S, Albrich W, Brun-Buisson C. Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. Emerg Infect Dis. 2002; 8: 1460–67.
   PubMed Web of Science ®Google Scholar
• Granizo J, Aguilar L, Casal J, Garcia-Rey C, Dal-Re R, Baquero F. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and B-lactam consumption in Spain (1979–1997). J Antimicrob Chemother. 2000; 46: 767–73.
   PubMed Web of Science ®Google Scholar
• Albrich WC, Monnet DL, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes . Emerg Infect Dis. 2004; 10: 514–17.
   PubMed Web of Science ®Google Scholar
• Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005; 365: 579–87.
   PubMed Web of Science ®Google Scholar
• Bronzwaer S, Cars O, Bucholz U, Molstad S, Goettsch W, Veldhuijzen IK, etal. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis. 2002; 8: 278–82.
   PubMed Web of Science ®Google Scholar
• Alexander Project Study Group. Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption?. J Chemother. 1999; 11: 35–43.
   Web of Science ®Google Scholar
• Singleton RJ, Hennessy TW, Bulkow LR. Invasive pneumococcal disease caused by non-vaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007; 297: 1784–1792.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. M100-S10. 2000; Wayne, PA: National Committee for Clinical Laboratory Standards.
   Google Scholar
• Roumie CL, Halasa NB, Grijalva CG, Edwards KM, Zhu Y, Dittus RS, etal. Trends in antibiotic prescribing for adults in the United States – 1995–2002. J Gen Intern Med. 2005; 20: 697–702.
   PubMed Web of Science ®Google Scholar
• McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 2002; 287: 3096–102.
   PubMed Web of Science ®Google Scholar
• Bott AM, Bruce MG, Bulkow L, Coleman J, Hennessy TW. Trends in antimicrobial prescribing rates for Alaska native and American Indian persons <18 years of age residing in the anchorage region. Int J Circumpolar Health. 2009; 68: 337–46.
   PubMed Web of Science ®Google Scholar
• Seppala H, Klaukka T, Lehtonen , Nenonen E, Huovinen P. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis. 1995; 21: 1378–85.
   PubMed Web of Science ®Google Scholar
• Spijkerman J, VanGils E, Veenhoven RH, Hak E, Yzerman EP, Van Der Ende A, etal. Carriage of streptococcus pneumoniae 3 years after start of vaccination program, The Netherlands. Emerg Infect Dis. 2011; 17: 584–91.
   PubMed Web of Science ®Google Scholar